about
Platelets in Pulmonary Immune Responses and Inflammatory Lung DiseasesProtein degradation systems in plateletsMutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndromeProteasome function is required for platelet productionGermline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiencyAbnormal megakaryocyte development and platelet function in Nbeal2(-/-) miceCationic PAMAM dendrimers disrupt key platelet functions.Chemoproteomic discovery of AADACL1 as a regulator of human platelet activation.Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human plateletsPolyubiquinated protein depots in platelets and megakaryocytes from patients with ANKRD26-RT.RASA3 is a critical inhibitor of RAP1-dependent platelet activationGermline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia.Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation.Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets.Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs.Non-genomic activities of retinoic acid receptor alpha control actin cytoskeletal events in human platelets.Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytesA tour through the transcriptional landscape of platelets.Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation.Platelets: signaling cells in the immune continuum.Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis.The septic milieu triggers expression of spliced tissue factor mRNA in human platelets.Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signalingPlatelets: versatile effector cells in hemostasis, inflammation, and the immune continuumMegakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events.Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shockThe evolving role of platelets in inflammation.Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes.mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets.Dengue virus pirates human plateletsWhole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques.Translational control in endothelial cells.In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1)Signaling to translational control pathways: diversity in gene regulation in inflammatory and vascular cells.Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets.VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock.Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets.Activated polymorphonuclear leukocytes rapidly synthesize retinoic acid receptor-alpha: a mechanism for translational control of transcriptional events.New roles for an old drug: inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates.Lessons from rare maladies: leukocyte adhesion deficiency syndromes.
P50
Q26739670-F9A9ABF0-3475-4A18-9090-EBEC3C1711E1Q27693902-F87D2C3B-D07C-4F75-8B66-668236EA3867Q28243405-FDF5BC69-EDF3-4458-B864-D0A8E8F9A6E8Q28244689-B1CD440B-A735-4478-BF6D-22FC6787354AQ28300499-AEC506E6-2761-45CF-98EA-C496749EB1AEQ28506840-B1983C77-7ABD-4A2A-94FE-4310EBEB07BEQ30514562-79D34308-CED9-4EDD-A735-CC07E11C8C9BQ30573816-F5C2FAC0-6FBF-4B29-B1F5-AC1D6A91A386Q33403953-B3AF1DC5-9C97-40DD-9808-373F9B23F679Q33405354-24EE36C3-84ED-4145-89B9-FFBE5BDC98AAQ33420627-204EB078-2B6C-41AF-B2FC-F7B4404AD581Q33421439-533E59EF-D893-4CE9-89BB-6B4BE37F1CDCQ33429010-2E10CB16-4FA2-4433-BD6A-7BB3B6E8B2DEQ33429232-A0BC92FB-D2E5-45AE-964D-943DD348C188Q33782606-802E23D9-A403-4509-B1D8-867529D05205Q33872647-42566D33-8B1F-430B-88B2-F2C6736E4CEEQ33943133-AFCE609F-C146-4AE9-8CF9-F52A0E271B8CQ33948696-82E98CD5-7931-4B46-8274-44A212107D3FQ34079154-74743C6C-D154-4078-93C2-37D8B97C13A6Q34342687-C9848704-B7E5-4D7F-BA06-BDE4A9584050Q34556967-2FE379FB-8987-4069-96A8-AFCAE77822DAQ34765561-FEBCB5B2-CF42-4CFD-89C9-0B4E2EF299FFQ35039893-968E85FC-1FC0-47AE-AADC-2BF85ABC66B8Q35101184-42F24184-ABE2-4B09-9B9C-97206B747953Q35172479-302D8F61-68C7-4F60-B3FF-5DF543DB71F1Q35197349-E3F7DEC7-DC57-4D34-9AD5-B17FF11A980FQ35206747-F176D2BF-CCCF-415F-9DD4-AD2BC961B076Q35346534-ABB9C94B-A4EE-4090-A41B-B72A3322336DQ35642870-732C5634-E05C-4423-8B52-7135769FD9F6Q35859207-01D48B89-10A2-4060-B7A6-3A2F718447F9Q35881752-EABA937E-2E78-4F50-A518-96FCBDFF3500Q35924824-EC8FA8E9-34AE-4271-A526-E5854715AD3CQ36009103-2592BC4E-A014-46CB-8DE3-D536059EA609Q36082283-87AB7FD8-4EA7-4A88-9A6C-C364CA1DE624Q36228070-DEF56D30-F81A-4C09-A965-589115449216Q36243227-2CFA5F18-4401-411A-B5F6-2CDD79674C09Q36288115-81335D58-8899-4ABB-963E-5A9F4A59D005Q36402452-7099E396-FC62-45FD-86DA-797390ABF2B0Q36425100-A6B0153C-D07C-437A-BC56-5D3ADB43479CQ36588205-0D63D3FC-6E69-4BE2-BD26-6876C2BE8265
P50
description
researcher
@en
wetenschapper
@nl
name
A S Weyrich
@en
A S Weyrich
@nl
type
label
A S Weyrich
@en
A S Weyrich
@nl
prefLabel
A S Weyrich
@en
A S Weyrich
@nl
P106
P31
P496
0000-0001-9622-4647